CLSDQ
Clearside Biomedical, Inc.
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Revenue
$1.7M
↓ 79.8%
Net Income
$-34352000
↓ 5.7%
Operating Income
$-28882000
↓ 16.3%
EPS (Diluted)
$-0.47
↑ 11.3%
Total Assets
$25.1M
↓ 26.1%
Total Liabilities
$64.0M
↑ 28.1%
Shareholders' Equity
$-38855000.00
↓ 144.2%
Cash & Equivalents
$20.0M
↓ 30.8%

Recent SEC Filings

Form Type Filed Date Link
15-12G 1/7/2026 View on SEC
8-K 12/29/2025 View on SEC
EFFECT 12/16/2025 View on SEC
EFFECT 12/16/2025 View on SEC
S-8 POS 12/15/2025 View on SEC
S-8 POS 12/15/2025 View on SEC
S-8 POS 12/15/2025 View on SEC
S-8 POS 12/15/2025 View on SEC
S-8 POS 12/15/2025 View on SEC
S-8 POS 12/15/2025 View on SEC

Company Information

Field Value
Ticker CLSDQ
Company Name Clearside Biomedical, Inc.
CIK 1539029
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 678-270-3631